do-me/EUR-LEX huggingface dataset:
Case T-249/24: Action brought on 13 May 2024 – Serana Europe v EUIPO – Cytogen Produkte für Medizin + Forschung (Amniogrow)
Date: 2024-05-13
Institutions: General Court
Subjects: EU trade mark, biotechnology, cytology, genetics, medical research, registered trade mark, trade-mark law








C_202403800EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3800


24.6.2024






Action brought on 13 May 2024 – Serana Europe v EUIPO – Cytogen Produkte für Medizin + Forschung (Amniogrow)


(Case T-249/24)

(C/2024/3800)
Language in which the application was lodged: German

Parties


Applicant: Serana Europe GmbH (Pessin, Germany) (represented by: T. Bösling and I. George, lawyers)

Defendant: European Union Intellectual Property Office

Other party to the proceedings before the Board of Appeal: Cytogen Produkte für Medizin + Forschung GmbH (Greven, Germany)

Details of the proceedings before EUIPO


Applicant for the trade mark at issue: Applicant

Trade mark at issue: Application for the EU trade mark Amniogrow – Application No 18 567 544
         

Proceedings before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 12 March 2024 in Case R 1705/2023-2

Form of order sought

The applicant claims that the Court should:






—


amend the contested decision to the effect that the opposition filed by Cytogen Produkte für Medizin + Forschung GmbH against EU trade mark application No 18 567 544
                  ‘Amniogrow’ is rejected and the appellant before the Board of Appeal is ordered to pay the costs of the proceedings before the Board of Appeal;










—


in the alternative, annul the contested decision;










—


order EUIPO to pay the costs.





Plea in law

Infringement of Article 8(4) in conjunction with Article 71 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.


ELI: http://data.europa.eu/eli/C/2024/3800/oj
ISSN 1977-091X (electronic edition)
Judgment of the Court of 13 May 2024 in Case E-7/23 – ExxonMobil Holding Norway AS v Staten v/ Skatteetaten (the Norwegian State, represented by the Tax Administration) (Freedom of establishment – Articles 31 and 34 EEA – Balanced allocation of taxation powers – Concept of final losses – Deduction of losses of a non-resident subsidiary –Even minimal income)
Date: 2024-05-13
Institutions: EFTA Court
Subjects: European Economic Area, Norway, basis of tax assessment, company law, loss, profit, right of establishment, subsidiary, tax relief, taxable income








C_202405660EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/5660


19.9.2024







            JUDGMENT OF THE COURT
         
of 13 May 2024
         
in Case E-7/23
ExxonMobil Holding Norway AS v Staten v/ Skatteetaten (the Norwegian State, represented by the Tax Administration)


(Freedom of establishment – Articles 31 and 34 EEA – Balanced allocation of taxation powers – Concept of ‘final losses’ – Deduction of losses of a non-resident subsidiary –Even minimal income)


(C/2024/5660)

In Case E-7/23, ExxonMobil Holding Norway AS v Staten v/ Skatteetaten (the Norwegian State, represented by the Tax Administration) – REQUEST to the Court under Article 34 of the Agreement between the EFTA States on the Establishment of a Surveillance Authority and a Court of Justice by Borgarting Court of Appeal (Borgarting lagmannsrett), concerning the interpretation of Article 31 of the Agreement on the European Economic Area as regards the possibility for ExxonMobil Holding Norway AS to deduct from its taxable income the losses of a subsidiary established in another EEA State, the Court, composed of Páll Hreinsson, President (Judge-Rapporteur), Bernd Hammermann and Ola Mestad (ad hoc), Judges, gave judgment on 13 May 2024, the operative part of which is as follows:






1.


It is compatible with Articles 31 and 34 EEA to require that the application of the ‘final losses’ exception within the meaning of the Court’s judgment in Case E-15/16 Yara is precluded where a non-resident subsidiary is in receipt of even minimal income in the fiscal year after the year for which a deduction is claimed.










2.


It is compatible with Articles 31 and 34 EEA for an EEA State to require, in order to demonstrate that a loss is final, that a liquidation process be formally decided upon immediately after the end of the fiscal year for which a deduction is claimed.






ELI: http://data.europa.eu/eli/C/2024/5660/oj
ISSN 1977-091X (electronic edition)
Case T-250/24: Action brought on 13 May 2024 – Serana Europe v EUIPO – Cytogen Produkte für Medizin + Forschung (Lymphogrow)
Date: 2024-05-13
Institutions: General Court
Subjects: EU trade mark, biotechnology, cytology, genetics, hiring, registered trade mark, trade-mark law








C_202403801EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3801


24.6.2024






Action brought on 13 May 2024 – Serana Europe v EUIPO – Cytogen Produkte für Medizin + Forschung (Lymphogrow)


(Case T-250/24)

(C/2024/3801)
Language in which the application was lodged: German

Parties


Applicant: Serana Europe GmbH (Pessin, Germany) (represented by: T. Bösling and I. George, lawyers)

Defendant: European Union Intellectual Property Office

Other party to the proceedings before the Board of Appeal: Cytogen Produkte für Medizin + Forschung GmbH (Greven, Germany)

Details of the proceedings before EUIPO


Applicant for the trade mark at issue: Applicant

Trade mark at issue: Application for the EU word mark Lymphogrow – Application No 18 567 547
         

Proceedings before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 12 March 2024 in Case R 1707/2023-2

Form of order sought

The applicant claims that the Court should:






—


amend the contested decision to the effect that the opposition filed by Cytogen Produkte für Medizin + Forschung GmbH against EU trade mark application No 18 567 547
                  ‘Lymphogrow’ is rejected and the appellant before the Board of Appeal is ordered to pay the costs of the proceedings before the Board of Appeal;










—


in the alternative, annul the contested decision;










—


order EUIPO to pay the costs.





Plea in law

Infringement of Article 8(4) in conjunction with Article 71 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.


ELI: http://data.europa.eu/eli/C/2024/3801/oj
ISSN 1977-091X (electronic edition)
Euro exchange rates – 8 May 2024
Date: 2024-05-13
Institutions: European Commission
Subjects: euro, exchange rate, money








C_202402525EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/2525


13.5.2024






Euro exchange rates (1)


            8 May 2024
         
(C/2024/2525)


1 euro =











 


Currency


Exchange rate




USD


US dollar


1,0743 




JPY


Japanese yen


167,15 




DKK


Danish krone


7,4599 




GBP


Pound sterling


0,86083 




SEK


Swedish krona


11,7330 




CHF


Swiss franc


0,9770 




ISK


Iceland króna


150,10 




NOK


Norwegian krone


11,7570 




BGN


Bulgarian lev


1,9558 




CZK


Czech koruna


25,036 




HUF


Hungarian forint


388,88 




PLN


Polish zloty


4,3075 




RON


Romanian leu


4,9757 




TRY


Turkish lira


34,6564 




AUD


Australian dollar


1,6374 




CAD


Canadian dollar


1,4784 




HKD


Hong Kong dollar


8,3989 




NZD


New Zealand dollar


1,7948 




SGD


Singapore dollar


1,4572 




KRW


South Korean won


1 466,47 




ZAR


South African rand


20,0409 




CNY


Chinese yuan renminbi


7,7651 




IDR


Indonesian rupiah


17 270,98 




MYR


Malaysian ringgit


5,0949 




PHP


Philippine peso


61,643 




RUB


Russian rouble


 




THB


Thai baht


39,717 




BRL


Brazilian real


5,4682 




MXN


Mexican peso


18,1936 




INR


Indian rupee


89,7015 






(1)  
            Source: reference exchange rate published by the ECB.


ELI: http://data.europa.eu/eli/C/2024/2525/oj
ISSN 1977-091X (electronic edition)
Case T-253/24: Action brought on 13 May 2024 – UV and Others v Commission
Date: 2024-05-13
Institutions: General Court
Subjects: European official, pension scheme, retirement conditions, staff regulations (EU)








C_202403803EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/3803


24.6.2024






Action brought on 13 May 2024 – UV and Others v Commission


(Case T-253/24)

(C/2024/3803)
Language of the case: French

Parties


Applicants: UV, UW, UY and UZ (represented by: S. Orlandi, lawyer)

Defendant: European Commission

Form of order sought

The applicants claim that the Court should:






—


annul the decision of 28 June 2023 rejecting the requests made by the applicants on 24 April 2023;










—


order the European Commission to pay the costs.





Pleas in law and main arguments

In support of the action against the decision rejecting their requests to apply Articles 21 and 22 of Annex XIII to the Staff Regulations of Officials of the Union in order to determine their retirement age and the rate of accrual of their pension rights, the applicants rely on a principal plea and an alternative plea which are identical or similar to those relied on in Case T-131/24, CR v Commission.


ELI: http://data.europa.eu/eli/C/2024/3803/oj
ISSN 1977-091X (electronic edition)
Euro exchange rates – 10 May 2024
Date: 2024-05-13
Institutions: European Commission
Subjects: euro, exchange rate, money








C_202402528EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2024/2528


13.5.2024






Euro exchange rates (1)


            10 May 2024
         
(C/2024/2528)


1 euro =











 


Currency


Exchange rate




USD


US dollar


1,0779 




JPY


Japanese yen


167,87 




DKK


Danish krone


7,4607 




GBP


Pound sterling


0,86055 




SEK


Swedish krona


11,6865 




CHF


Swiss franc


0,9779 




ISK


Iceland króna


150,30 




NOK


Norwegian krone


11,6735 




BGN


Bulgarian lev


1,9558 




CZK


Czech koruna


24,936 




HUF


Hungarian forint


387,72 




PLN


Polish zloty


4,2968 




RON


Romanian leu


4,9758 




TRY


Turkish lira


34,7431 




AUD


Australian dollar


1,6320 




CAD


Canadian dollar


1,4747 




HKD


Hong Kong dollar


8,4228 




NZD


New Zealand dollar


1,7923 




SGD


Singapore dollar


1,4592 




KRW


South Korean won


1 472,72 




ZAR


South African rand


19,8673 




CNY


Chinese yuan renminbi


7,7877 




IDR


Indonesian rupiah


17 292,10 




MYR


Malaysian ringgit


5,1082 




PHP


Philippine peso


61,936 




RUB


Russian rouble


 




THB


Thai baht


39,580 




BRL


Brazilian real


5,5332 




MXN


Mexican peso


18,0730 




INR


Indian rupee


90,0185 






(1)  
            Source: reference exchange rate published by the ECB.


ELI: http://data.europa.eu/eli/C/2024/2528/oj
ISSN 1977-091X (electronic edition)